LL-37

Human cathelicidin antimicrobial peptide

Human cathelicidin. Innate immune modulation. 3 mg lyophilized vial.

DOSE

3 MG LYO

QUANTITY

BUNDLE & SAVE

$164.00

COA

SHIPS

FRI · 2-5 BIZ DAYS

PAY WITH

USDC · SOLANA

VIEW RESEARCH ↓RESEARCH USE ONLY · NOT FOR HUMAN CONSUMPTION

REFERENCE

RESEARCH

COMPOUND DATA AND PEER-REVIEWED CITATIONS FOR LL-37. FOR RESEARCH USE ONLY.

COMPOUND INFORMATION · TECHNICAL SPECIFICATIONS

MOLECULAR PROFILE

WHAT IS LL-37?

TYPE: Peptide
CAS: 154947-66-7
MOL. WEIGHT: 4493 g/mol
FORMULA: C205H340N60O53
DOSE: 3 MG LYO

SYNONYMS

LL-37ropocamptideCap-18cathelicidin LL-37CAP18Antibacterial peptide LL-37

PUBCHEM DATABASE →

STORAGE REQUIREMENTS

STABILITY INFORMATION

Protect from lightAvoid repeated freeze-thawReconstitute with bacteriostatic water

LYOPHILIZED (POWDER)

-20°C · up to 2 years

RECONSTITUTED

2-8°C · up to 30 days

SOURCES & REFERENCES · PEER-REVIEWED RESEARCH · 8 CITATIONS FOR LL-37

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Vitamin D triggers hCAP18/LL-37 production: Implications for LL-37-induced human osteoblast cytotoxicity.

2024 · PMID 38642493

Aidoukovitch A, Bankell E et al.

VIEW SOURCE →

CELL REPORTS

LL-37 transports immunoreactive cGAMP to activate STING signaling and enhance interferon-mediated host antiviral immunity.

2022 · PMID 35649354

Wei X, Zhang L et al.

VIEW SOURCE →

CELLS

IMPORTANT RESEARCH NOTICE

NOT FOR HUMAN CONSUMPTION. THIS PRODUCT IS SOLD EXCLUSIVELY FOR RESEARCH AND EDUCATIONAL PURPOSES. IT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE.

ALL CITATIONS ON THIS PAGE ARE SOURCED FROM PUBMED AND PUBCHEM PUBLIC DATABASES. THEY ARE PROVIDED FOR EDUCATIONAL REFERENCE ONLY AND SHOULD NOT BE INTERPRETED AS MEDICAL ADVICE OR PRODUCT CLAIMS.

BY PURCHASING THIS PRODUCT, YOU CONFIRM THAT YOU ARE A QUALIFIED RESEARCHER AND WILL USE IT IN ACCORDANCE WITH ALL APPLICABLE LAWS.